Floatz logo

Adalimumab

Sleep Apnea, Obstructive

Innovaderm Research Inc.monoclonal_antibodyPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Sleep Apnea, Obstructive cohort.

Asset / SponsorPhaseRating
MELATONIN
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 4BB
Liraglutide
St Vincent's University Hospital, Ireland
Phase 3BB
xw003
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3B
Eloralintide
Eli Lilly and Company
Phase 3B
Mazdutide
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3B

View all 16 →

Same molecule, other indications

Adalimumab is also rated in:

psoriasisDormant
BB
Indicative ·
68 / 100
View asset →
sciaticaDormant
B
Indicative ·
57 / 100
View asset →
Netherton syndromeDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →